Cargando…

The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease

BACKGROUND/AIMS: Nonalcoholic fatty liver disease (NAFLD) is closely associated with diabetes. The cumulative impact of both diseases synergistically increases risk of adverse events. However, present population analysis is predominantly conducted with reference to non-NAFLD individuals and has not...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ng, Cheng Han, Chan, Kai En, Chin, Yip Han, Zeng, Rebecca Wenling, Tsai, Pei Chen, Lim, Wen Hui, Tan, Darren Jun Hao, Khoo, Chin Meng, Goh, Lay Hoon, Ling, Zheng Jye, Kulkarni, Anand, Mak, Lung-Yi Loey, Huang, Daniel Q, Chan, Mark, Chew, Nicholas WS, Siddiqui, Mohammad Shadab, Sanyal, Arun J., Muthiah, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293620/ https://www.ncbi.nlm.nih.gov/pubmed/35585687 http://dx.doi.org/10.3350/cmh.2022.0096

Ejemplares similares

Foregut bypass vs. restrictive bariatric procedures for nonalcoholic fatty liver disease: a meta-analysis of 3,355 individuals
por: Lim, Wen Hui, et al.
Publicado: (2022)

The placebo response rate and nocebo events in obesity pharmacological trials. A systematic review and meta-analysis
por: Chin, Yip Han, et al.
Publicado: (2022)

Historical Changes in Weight Classes and the Influence of NAFLD Prevalence: A Population Analysis of 34,486 Individuals
por: Nah, Benjamin Kai Yi, et al.
Publicado: (2022)

Drug discovery and treatment paradigms in nonalcoholic steatohepatitis
por: Noureddin, Mazen, et al.
Publicado: (2019)

A qualitative systematic review of anonymous/unspecified living kidney and liver donors’ perspectives
por: Lim, Wen Hui, et al.
Publicado: (2022)

A Class Effect Network Meta-analysis of Lipid Modulation in Non-alcoholic Steatohepatitis for Dyslipidemia
por: Xiao, Jieling, et al.
Publicado: (2022)

Can glucose‐lowering medications improve outcomes in non‐diabetic heart failure patients? A Bayesian network meta‐analysis
por: Yeong, Trevor, et al.
Publicado: (2022)

Depression in non-alcoholic fatty liver disease is associated with an increased risk of complications and mortality
por: Ng, Cheng Han, et al.
Publicado: (2022)

A poor perspective of self weight significantly increases adverse outcomes in non-alcoholic fatty liver disease (NAFLD)
por: Fu, Clarissa Elysia, et al.
Publicado: (2022)

The genetic interactions between non-alcoholic fatty liver disease and cardiovascular diseases
por: Chew, Nicholas W.S., et al.
Publicado: (2022)

General Public’s knowledge, awareness, and perception of Cardiometabolic diseases: data from a Singapore study population
por: Anand, Vickram Vijay, et al.
Publicado: (2023)

Global incidence and prevalence of nonalcoholic fatty liver disease
por: Teng, Margaret LP, et al.
Publicado: (2023)

Glucagon-Like Peptide-1 Receptor Agonists for Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: A Meta-Analysis
por: Wong, Chloe, et al.
Publicado: (2021)

DEXA Scan Body Fat Mass Distribution in Obese and Non-Obese Individuals and Risk of NAFLD—Analysis of 10,865 Individuals
por: Tan, Caitlyn, et al.
Publicado: (2022)

Sodium-Glucose Co-Transporter 2 Inhibitors for Non-Alcoholic Fatty Liver Disease in Asian Patients With Type 2 Diabetes: A Meta-Analysis
por: Wong, Chloe, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals
por: Tang, Ansel Shao Pin, et al.
Publicado: (2022)

Hepatic inflammation: an important target for biomarker development in nonalcoholic fatty liver disease
por: Khan, Hiba, et al.
Publicado: (2023)

A Time-Based Meta-Analysis on the Incidence of New Onset Diabetes after Liver Transplantation
por: Chin, Yip Han, et al.
Publicado: (2021)

Trends and predictions of malnutrition and obesity in 204 countries and territories: an analysis of the Global Burden of Disease Study 2019
por: Chong, Bryan, et al.
Publicado: (2023)

Hypertension is prevalent in non-alcoholic fatty liver disease and increases all-cause and cardiovascular mortality
por: Ng, Cheng Han, et al.
Publicado: (2022)

Harnessing Muscle–Liver Crosstalk to Treat Nonalcoholic Steatohepatitis
por: Chakravarthy, Manu V., et al.
Publicado: (2020)

Editorial: The heart of NAFLD
por: Chew, Nicholas W. S., et al.
Publicado: (2023)

A Smartphone App-Based Lifestyle Change Program for Prediabetes (D'LITE Study) in a Multiethnic Asian Population: A Randomized Controlled Trial
por: Lim, Su Lin, et al.
Publicado: (2022)

Tocotrienol in the Management of Nonalcoholic Fatty Liver Disease: A Systematic Review
por: Chin, Kok-Yong, et al.
Publicado: (2023)

Prevalence of Prediabetes and Diabetes and Metabolic Profile of Patients With Nonalcoholic Fatty Liver Disease (NAFLD)
por: Ortiz-Lopez, Carolina, et al.
Publicado: (2012)

Subclinical inflammation in relation to insulin resistance in prediabetic subjects with nonalcoholic fatty liver disease
por: Hossain, Israt Ara, et al.
Publicado: (2016)

The Association of Plant-Based Diet With Cardiovascular Disease and Mortality: A Meta-Analysis and Systematic Review of Prospect Cohort Studies
por: Quek, Jingxuan, et al.
Publicado: (2021)

The transcontinental variability of nonalcoholic fatty liver disease
por: Oliveira, Claudia P., et al.
Publicado: (2020)

Efficacy and Moderation of Mobile App–Based Programs for Mindfulness-Based Training, Self-Compassion Training, and Cognitive Behavioral Psychoeducation on Mental Health: Randomized Controlled Noninferiority Trial
por: Mak, Winnie WS, et al.
Publicado: (2018)

Gender Specific Association of Serum Leptin and Insulinemic Indices with Nonalcoholic Fatty Liver Disease in Prediabetic Subjects
por: Hossain, Israt Ara, et al.
Publicado: (2015)

Effectiveness of Combined Health Coaching and Self-Monitoring Apps on Weight-Related Outcomes in People With Overweight and Obesity: Systematic Review and Meta-analysis
por: Chew, Han Shi Jocelyn, et al.
Publicado: (2023)

Association Between Mobile Health App Engagement and Weight Loss and Glycemic Control in Adults With Type 2 Diabetes and Prediabetes (D’LITE Study): Prospective Cohort Study
por: Lim, Su Lin, et al.
Publicado: (2022)

Gene-Environmental Interactions as Metabolic Drivers of Nonalcoholic Steatohepatitis
por: Albhaisi, Somaya, et al.
Publicado: (2021)

Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science
por: Siddiqui, Mohammad Shadab, et al.
Publicado: (2018)

Safety and tolerability of obeticholic acid in chronic liver disease: a pooled analysis of 1878 individuals
por: Ng, Cheng Han, et al.
Publicado: (2023)

Neck Circumference to Height Ratio is a Reliable Predictor of Liver Stiffness and Nonalcoholic Fatty Liver Disease in Prediabetes
por: Mondal, Samim Ali, et al.
Publicado: (2018)

Prediabetes and Type 2 Diabetes are Independent Risk Factors for Computed Tomography-Estimated Nonalcoholic Fatty Pancreas Disease
por: Ahbab, Süleyman, et al.
Publicado: (2019)

Comparing the Frequency of Some Oral Lesions in Prediabetic and Healthy Individuals: Is There Any Difference?
por: Anari, Akram Ghadiri, et al.
Publicado: (2019)

Curcumin Nanoformulations for Colorectal Cancer: A Review
por: Wong, Kar En, et al.
Publicado: (2019)

Dietary Patterns and the Risk of Prediabetes in Taiwan: A Cross-Sectional Study
por: Hou, Yi-Cheng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g9tm0g95fll6rakgq14slcnv8v